These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1282782

  • 1. Extent and course of glomerular injury in human membranous glomerulopathy.
    Guasch A, Sibley RK, Huie P, Myers BD.
    Am J Physiol; 1992 Dec; 263(6 Pt 2):F1034-43. PubMed ID: 1282782
    [Abstract] [Full Text] [Related]

  • 2. The biophysical basis of hypofiltration in nephrotic humans with membranous nephropathy.
    Ting RH, Kristal B, Myers BD.
    Kidney Int; 1994 Feb; 45(2):390-7. PubMed ID: 8164424
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of progressive glomerular injury in membranous nephropathy.
    Squarer A, Lemley KV, Ambalavanan S, Kristal B, Deen WM, Sibley R, Anderson L, Myers BD.
    J Am Soc Nephrol; 1998 Aug; 9(8):1389-98. PubMed ID: 9697660
    [Abstract] [Full Text] [Related]

  • 4. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R, Wenting GJ, Kramer P, Schalekamp MA, Weimar W.
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [Abstract] [Full Text] [Related]

  • 5. Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease.
    Austin SM, Lieberman JS, Newton LD, Mejia M, Peters WA, Myers BD.
    J Am Soc Nephrol; 1993 Jan; 3(7):1358-70. PubMed ID: 8439648
    [Abstract] [Full Text] [Related]

  • 6. Extent of glomerular injury in active and resolving lupus nephritis: a theoretical analysis.
    Myers BD, Chagnac A, Golbetz H, Newton L, Strober S, Sibley RK.
    Am J Physiol; 1991 May; 260(5 Pt 2):F717-27. PubMed ID: 2035658
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G.
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [Abstract] [Full Text] [Related]

  • 8. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
    Tomlanovich S, Deen WM, Jones HW, Schwartz HC, Myers BD.
    Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
    [Abstract] [Full Text] [Related]

  • 9. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
    Morita M, Mii A, Shimizu A, Yasuda F, Shoji J, Masuda Y, Ohashi R, Nagahama K, Kaneko T, Tsuruoka S.
    PLoS One; 2015 May; 10(4):e0116700. PubMed ID: 25875837
    [Abstract] [Full Text] [Related]

  • 10. Permselectivity in thin membrane nephropathy.
    Thomas DM, Coles GA, Griffiths DF, Williams JD.
    J Clin Invest; 1994 May; 93(5):1881-4. PubMed ID: 7514188
    [Abstract] [Full Text] [Related]

  • 11. Nature of the glomerular capillary injury in human membranous glomerulopathy.
    Shemesh O, Ross JC, Deen WM, Grant GW, Myers BD.
    J Clin Invest; 1986 Mar; 77(3):868-77. PubMed ID: 2419362
    [Abstract] [Full Text] [Related]

  • 12. Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy.
    Tsuboi N, Kawamura T, Miyazaki Y, Utsunomiya Y, Hosoya T.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3555-60. PubMed ID: 21771759
    [Abstract] [Full Text] [Related]

  • 13. Molecular configuration and glomerular size selectivity in healthy and nephrotic humans.
    Blouch K, Deen WM, Fauvel JP, Bialek J, Derby G, Myers BD.
    Am J Physiol; 1997 Sep; 273(3 Pt 2):F430-7. PubMed ID: 9321916
    [Abstract] [Full Text] [Related]

  • 14. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics.
    Thomas DM, Hillis AN, Coles GA, Davies M, Williams JD.
    Am J Kidney Dis; 1991 Jul; 18(1):38-43. PubMed ID: 1712151
    [Abstract] [Full Text] [Related]

  • 15. Lupus and nonlupus membranous glomerulopathy. Quantitative comparison of the subepithelial deposits and glomerular basement membrane including clinicomorphologic correlations.
    Danilewicz M, Wagrowska-Danilewicz M.
    Gen Diagn Pathol; 1997 Jun; 142(5-6):305-10. PubMed ID: 9228253
    [Abstract] [Full Text] [Related]

  • 16. Correlation between histologic features and glomerular permeability in membranous nephropathy and immunoglobulin A nephropathy.
    Ikegaya N, Nagase M, Honda N, Kumagai H, Hishida A.
    J Lab Clin Med; 1994 Jan; 123(1):94-101. PubMed ID: 7507157
    [Abstract] [Full Text] [Related]

  • 17. Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis.
    Guasch A, Hashimoto H, Sibley RK, Deen WM, Myers BD.
    Am J Physiol; 1991 May; 260(5 Pt 2):F728-37. PubMed ID: 1709791
    [Abstract] [Full Text] [Related]

  • 18. [Case of MPO-ANCA-associated vasculitis with membranous nephropathy].
    Watanabe S, Arimura Y, Nomura K, Kawashima S, Yoshihara K, Kaname S, Yamada A.
    Nihon Jinzo Gakkai Shi; 2011 May; 53(1):46-52. PubMed ID: 21370577
    [Abstract] [Full Text] [Related]

  • 19. Podocytopenia and disease severity in IgA nephropathy.
    Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD.
    Kidney Int; 2002 Apr; 61(4):1475-85. PubMed ID: 11918755
    [Abstract] [Full Text] [Related]

  • 20. Determinants of GFR depression in early membranous nephropathy.
    Hladunewich MA, Lemley KV, Blouch KL, Myers BD.
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1014-22. PubMed ID: 12527555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.